2. Members
There are thirteen (13) members of EXCO as follows:
• President & Managing Director
• Vice President I – Business Operations & Clinical
Services
• Vice President I – Corporate & Financial Services
• Vice President I – Project Management & Biomedical
Services
• Vice President II – Business Development Services
• Vice President II – Group Talent Management Services
• Senior General Manager – Group Operation
(Executive Director)
• Senior General Manager – Group Operation
(International)
• Senior General Manager – Group Finance Services
• Senior General Manager – Group Corporate
Communication & Wellness
• Senior General Manager – Group Operation
(Executive Director)
• Senior General Manager – Group Operation
(Executive Director)
• Chief Information Officer
3. Meetings
Meetings are usually held on every Tuesday of the week.
Tender Evaluation Committee (TEC)
In an effort to achieve high standards of corporate
governance, the Board had in February 2014 resolved to
establish the Tender Evaluation Committee (TEC). The
main purpose of the Committee is to evaluate and make
its recommendations to the TBC on major purchases,
acquisitions or disposals of assets, awards of contracts
and appointments of consultants/advisors for the Group.
The members of the TEC are:
a)
Mohd Sahir Rahmat (Chairman) – Vice President (I),
Corporate & Financial Services
b) Jasimah Hassan – Vice President (I), Business
Operations & Clinical Services
c)
Abdul Malek Talib – Vice President (I), Project
Management & Biomedical Services
d) Ahmad Nasirruddin Harun – Senior General Manager
– Group Operation (Executive Director)
e)
Mohd Johar Ismail – Senior General Manager, Group
Operations (International)
In 2014, the TEC met five (5) times and made its findings
and recommendations to the TBC as required.
Internal Audit Function
The Board acknowledges its primary responsibility for the
Group’s system of internal controls and risk management.
The effectiveness of the system of internal controls and
risk management of the Group is reviewed by the Audit
Committee. A more detailed discussion is set out in the
Statement on Risk Management and Internal Control as
well as the Audit Committee Report on pages 168 to 177
of this Annual Report.
7. Ensure Timely and High Quality Disclosure
Corporate Disclosure Policy
The Company has in place procedures for compliance
with the MMLR and ensures that all material information
are announced immediately to Bursa Securities as
required.
Leverage on Information Technology
The corporate website at
is
maintained to disseminate information and create greater
awareness of the Group activities, performance and other
relevant information for the benefit of all stakeholders
and general public.
The Group also has a dedicated website for Investor
Relations where all information relating to quarterly
result announcements, Annual Reports, changes to
shareholding and press releases are published
concurrently with Bursa Malaysia website. This website
also sends out alerts to investors for any announcement
made in relation to the Company.
8. Strengthen Relationship with the Shareholders
Shareholder Participation at the AGM
At each AGM, the Chairman presents the progress and
performance of the Company, in addition to encouraging
shareholders to participate in the question-and-answer
session. The President & Managing Director, the
Chairman of the Audit Committee and other Board
Members are available to respond to shareholders’
questions during the meeting. Where appropriate, the
Chairman will undertake to provide a written answer to
any significant question that cannot be readily answered
at the meeting. Apart from the Board Chairman and
President & Managing Director, shareholders or
stakeholders may convey any concerns that they may
have to Zainah Mustafa, the Independent Non-Executive
Director who is also the Chairman of the Audit
Committee.
165
KPJ Healthcare Berhad annual report
2014
